Further, miR-Vimentin and miR-Mortalin breast cancer derived exosomes had Vimentin and Mortalin protein expression levels reduced to approximately 50% for MDA-MB-231 and MCF-7 (Fig. 6C,D). This evidence concerns the gene HSPA9 and breast carcinoma.